ENLV (Enlivex Therapeutics Ltd) Bozor qiymatining balans qiymatiga nisbati
Enlivex Therapeutics (ENLV) tadqiqot markazlari belgilangan jadval asosida ishlamoqda, hujayra asosidagi mahsulotlar hajmini oshirish uchun pudratchilarning quvvatini muntazam ravishda oshirib bormoqda. Hozirgi narx harakati 0.01 darajasiga yetib, immunitetni qayta dasturlash orqali sitokin bo'ronlariga qarshi kurashish usullarini ishlab chiqishga hamroh bo'ladi. Ta'minot barqarorligi va yuqori zanjirli rentabellik biomateriallarni juda past haroratlarda tashish texnologiyasiga ega bo'lgan ixtisoslashgan tashuvchilardan foydalanish orqali ta'minlanadi.
Enlivex Therapeutics (ENLV) - koʻrsatkichlar kesimi va moliyaviy hisobotlar
- aksiya narxi va baholash bo'yicha konsensus prognoz:
- biznesning bozor baholash ko'rsatkichlari:
- balans kapitallashuvi bo'yicha ma'lumotlar:
- qarz majburiyatlari va likvidlik statistikasi:
Qarzning xususiy kapitalga nisbati Enlivex Therapeutics|ENLV - Uzoq muddatli qarzning kapitalga koeffitsiyenti|Qisqa muddatli qarzning o'z kapitaliga nisbati enlivex.com|ENLV - Kompaniyaning umumiy qarzi|Balans kapitallashuviga qarzlar Enlivex Therapeutics, Ltd.|ENLV - Kompaniyaning uzoq muddatli qarzlari|Kompaniyaning qisqa muddatli majburiyatlari Enlivex Therapeutics|Tezkor likvidlik koeffitsiyenti enlivex.com
- foyda va baholash multiplikatorlari ko'rsatkichlari:
Kompaniyaning asosiy tahlili:Enlivex Therapeutics Ltd - ENLV
Sepsisga qarshi kurashish uchun hujayra texnologiyalarini ishlab chiqish sezilarli miqdorda tadqiqot va ishlanmalar (R&D) kapital xarajatlarini talab qiladi. Ushbu koeffitsient Enlivex Therapeutics (ENLV) bozor qiymatini uning sof aktivlariga solishtirib, kelajakdagi innovatsiyalar uchun qo'shimcha qiymatni aks ettiradi. Mazkur ko'rsatkich investorlarning haqiqiy balans hisoboti qiymatiga nisbatan qanchalik ortiq to'layotganini aniqlash imkonini beradi. Ushbu koeffitsientni tahlil qilish bozorning haddan tashqari qiziganini o'z vaqtida aniqlashga yordam beradi. Kompaniyaga tegishli baholashning P/B koeffitsienti orqali tarixi ushbu konsensus dinamikasini aniq namoyish etadi.
Raqobatchilar tahlili
ARGX (argenx SE) - Kapitallashuvning sof aktivlarga nisbati|BNTX (biontech.de) - Bozor qiymatining balans qiymatiga nisbati|Bozor qiymatining balans qiymatiga nisbati abivax.com|ADMA Biologics Inc - Sof aktivlarga nisbatan bozor kapitallashuvi|Bozor kapitallashuvining balans qiymatiga nisbati PTGX|IMVT (Immunovant Therapeutics) - Balans qiymatiga nisbatan bozor qiymati|Bozor kapitallashuvining balans qiymatiga nisbati KNSA (Kiniksa Pharmaceuticals)|Bozor kapitallashuvining balans qiymatiga nisbati grifols.com GRFS|ADPT - Bozor qiymatining balans qiymatiga nisbati|Balans qiymatiga nisbatan bozor qiymati CLDX (Celldex Therapeutics Inc)|Aurinia Pharma (AUPH) - Bozor qiymatining balans qiymatiga nisbati|Kapitallashuvning sof aktivlarga nisbati BioCryst Corp|VERA (Vera Therapeutics, Inc.) - Bozor kapitallashuvining balans qiymatiga nisbati|Bozor kapitallashuvining balans qiymatiga nisbati dianthustx.com|Kapitallashuvning sof aktivlarga nisbati PHVS (Pharvaris)|ABCL (AbCellera Biologics) - Balans qiymatiga nisbatan bozor qiymati|Bozor kapitallashuvining balans qiymatiga nisbati TRML (Tourmaline Corp)|Balans qiymatiga nisbatan bozor kapitallashuvi Precigen Corp (PGEN)|PHAR - Bozor qiymatining balans qiymatiga nisbati|nektar.com (NKTR) - Kapitallashuvning sof aktivlarga nisbati|Upstream Bio (UPB) - Bozor qiymatining balans qiymatiga nisbati|Kapitallashuvning sof aktivlarga nisbati Zenas Bio|Kapitallashuvning sof aktivlarga nisbati IMNM|Bozor kapitallashuvining balans qiymatiga nisbati Gossamer Bio Corp.|Bozor qiymatining balans qiymatiga nisbati KalVista Pharmaceuticals (KALV)|septerna.com - Kapitallashuvning balans qiymatiga nisbati|Bozor kapitallashuvining balans qiymatiga nisbati PVLA (Pieris Pharmaceuticals, Inc.)|Savara Inc (SVRA) - Bozor qiymatining balans qiymatiga koeffitsiyenti|Rigel Pharmaceuticals Inc - Bozor kapitallashuvining balans qiymatiga nisbati|Bozor qiymatining balans qiymatiga koeffitsiyenti AnaptysBio Inc.|Astria Therapeutics (ATXS) - Bozor qiymatining balans qiymatiga nisbati|Kapitallashuvning balans qiymatiga nisbati ENGN|Bozor qiymatining balans qiymatiga nisbati RAPT Therapeutics|Bozor qiymatining balans qiymatiga nisbati JBIO|Bozor kapitallashuvining balans qiymatiga nisbati ACRS|Balans qiymatiga nisbatan bozor kapitallashuvi Kyverna Therapeutics, Inc|Tiziana Life Sciences - Kapitallashuvning sof aktivlarga nisbati|cabalettabio.com - Bozor qiymatining balans qiymatiga nisbati|Ventyx Biosciences, Inc. - Bozor kapitallashuvining balans qiymatiga nisbati|Bozor qiymatining balans qiymatiga koeffitsiyenti Theratechnologies, Inc.|AVTX (Avalo Therapeutics Inc.) - Kapitallashuvning sof aktivlarga nisbati|Kapitallashuvning balans qiymatiga nisbati ELDN|Kapitallashuvning sof aktivlarga nisbati AGEN|CLYM: Balans qiymatiga nisbatan bozor qiymati|Kapitallashuvning sof aktivlarga nisbati ZURA (Zura Bio)|Bozor kapitallashuvining balans qiymatiga multiplikatori ATYR|Bozor kapitallashuvining balans qiymatiga nisbati ADAG (Adagene Inc.)|Balans qiymatiga nisbatan bozor qiymati IMA|Shattuck Therapeutics - Bozor kapitallashuvining balans qiymatiga nisbati|Bozor qiymatining balans qiymatiga koeffitsiyenti Equillium, Inc.|connectbiopharm.com (CNTB) - Bozor qiymatining balans qiymatiga nisbati|Immunic - Balans qiymatiga nisbatan bozor qiymati|ATRA (Atara Biotherapeutics, Inc.) - Bozor kapitallashuvining balans qiymatiga nisbati|Bozor kapitallashuvining balans qiymatiga nisbati InflaRx GmbH|Bozor qiymatining balans qiymatiga nisbati X4 Pharmaceuticals (XFOR)|ACET: Sof aktivlarga nisbatan bozor kapitallashuvi|Bozor kapitallashuvining balans qiymatiga nisbati CELU (Celularity)|INmune Bio Inc (INMB) - Bozor qiymatining balans qiymatiga koeffitsiyenti|BRNS: Kapitallashuvning sof aktivlarga nisbati|KZR - Bozor kapitallashuvining balans qiymatiga nisbati|SABS (SAB Biotherapeutics) - Kapitallashuvning sof aktivlarga nisbati|AKTX: Bozor kapitallashuvining balans qiymatiga multiplikatori|QTTB (Q32 Bio Inc) - Bozor kapitallashuvining balans qiymatiga nisbati|GeoVax Labs (GOVX) - Balans qiymatiga nisbatan bozor kapitallashuvi|Bozor kapitallashuvining balans qiymatiga nisbati EDSA|Kapitallashuvning sof aktivlarga nisbati iBio Corporation IBIO|Bozor qiymatining balans qiymatiga nisbati Carisma Therapeutics Inc. CARM|Balans qiymatiga nisbatan bozor kapitallashuvi xtlbio.com (XTLB)|Bolt Bio - Bozor kapitallashuvining balans qiymatiga nisbati|Bozor qiymatining balans qiymatiga koeffitsiyenti HCW Biologics Inc.|aptevotherapeutics.com (APVO) - Bozor qiymatining balans qiymatiga nisbati|Kapitallashuvning balans qiymatiga nisbati AIM|Bozor qiymatining balans qiymatiga nisbati Aditxt Inc.|Bozor qiymatining balans qiymatiga nisbati GRI|Kapitallashuvning sof aktivlarga nisbati XRTX (XORTX Therapeutics)|Bozor qiymatining balans qiymatiga nisbati HIND (Vyome Holdings Inc.)|Bozor qiymatining balans qiymatiga nisbati Revelation Bio REVB|INDP (Indaptus Corp) - Sof aktivlarga nisbatan bozor kapitallashuvi|Scinai Immunotherapeutics - Bozor kapitallashuvining balans qiymatiga nisbati|Balans qiymatiga nisbatan bozor qiymati CALI (CalciMedica, Inc.)|AFMD: Bozor kapitallashuvining balans qiymatiga nisbati|Allakos (ALLK) - Bozor kapitallashuvining balans qiymatiga nisbati|Bozor qiymatining balans qiymatiga nisbati HOOKIPA Pharma, Inc.|IGMS: Balans qiymatiga nisbatan bozor qiymati|Bozor qiymatining balans qiymatiga nisbati iTeos Therapeutics (ITOS)|Kapitallashuvning sof aktivlarga nisbati oceanbiomedical.com OCEA|Bozor kapitallashuvining balans qiymatiga nisbati TCBP (TC BioPharm)|Bozor kapitallashuvining balans qiymatiga nisbati Third Harmonic Bio Inc. THRD